DIARYLALKYLAMINE REV-ERB ANTAGONISTS AND THEIR USE AS MEDICAMENTS
申请人:FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA
公开号:US20160237057A1
公开(公告)日:2016-08-18
The present invention relates to compounds of Formula (I) or pharmaceutically acceptable salts or solvates thereof: It further discloses a pharmaceutical composition comprising the compounds of Formula (I) and their uses as anti-proliferative and pro-apoptotic agents for cancer therapy.